- Home
- FSCO vs IART Comparison
FSCO vs IART Comparison
Compare FSCO & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSCO
- IART
- Stock Information
- Founded
- FSCO 2013
- IART 1989
- Country
- FSCO United States
- IART United States
- Employees
- FSCO N/A
- IART N/A
- Industry
- FSCO Trusts Except Educational Religious and Charitable
- IART Medical/Dental Instruments
- Sector
- FSCO Finance
- IART Health Care
- Exchange
- FSCO Nasdaq
- IART Nasdaq
- Market Cap
- FSCO 1.3B
- IART 1.3B
- IPO Year
- FSCO N/A
- IART 1995
- Fundamental
- Price
- FSCO $6.50
- IART $23.00
- Analyst Decision
- FSCO
- IART Hold
- Analyst Count
- FSCO 0
- IART 8
- Target Price
- FSCO N/A
- IART $28.14
- AVG Volume (30 Days)
- FSCO 709.7K
- IART 1.1M
- Earning Date
- FSCO 01-01-0001
- IART 11-04-2024
- Dividend Yield
- FSCO 11.44%
- IART N/A
- EPS Growth
- FSCO N/A
- IART N/A
- EPS
- FSCO N/A
- IART N/A
- Revenue
- FSCO N/A
- IART $1,564,920,000.00
- Revenue This Year
- FSCO N/A
- IART $6.71
- Revenue Next Year
- FSCO N/A
- IART $6.08
- P/E Ratio
- FSCO N/A
- IART N/A
- Revenue Growth
- FSCO N/A
- IART 1.45
- 52 Week Low
- FSCO $4.08
- IART $16.81
- 52 Week High
- FSCO $6.00
- IART $45.42
- Technical
- Relative Strength Index (RSI)
- FSCO 43.14
- IART 55.94
- Support Level
- FSCO $6.49
- IART $21.97
- Resistance Level
- FSCO $6.69
- IART $23.01
- Average True Range (ATR)
- FSCO 0.07
- IART 1.16
- MACD
- FSCO -0.01
- IART -0.24
- Stochastic Oscillator
- FSCO 13.04
- IART 27.74
About FSCO FS Credit Opportunities Corp.
FS Credit Opp Corp. is a closed-end management investment company. The Fund's primary investment objective is to generate an attractive total return consisting of a high level of current income and capital appreciation, with a secondary objective of capital preservation. The Fund seeks to achieve its investment objectives by focusing on strategies such as Opportunistic Credit (including event-driven and market price inefficiencies), Special Situations, and Capital Structure Solutions.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.